Diaphorina citri psyllid: psy9231

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130----
MEHGPLPLAETIDHGRKNTQINFFILPGVSTMVKASLRTLLFISMSSFFPVFVWTGITSMDVLCKVCGDKASGKHYGVPSCDGCRGFFKRSIRRNLEYVCKERGHCIVDVTRRNQCQACRFSKCLQVKMNRDAM
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccCCccccccEEcccccccccccccHHHHccccEEEEcccccccccccccccccHHHHHHHHHcccccccc
***********************************************************MDVLCKVCGDKASGKHYGVPSCDGCRGFFKRSIRRNLEYVCKERGHCIVDVTRRNQCQACRFSKCLQVKMNR***
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MEHGPLPLAETIDHGRKNTQINFFILPGVSTMVKASLRTLLFISMSSFFPVFVWTGITSMDVLCKVCGDKASGKHYGVPSCDGCRGFFKRSIRRNLEYVCKERGHCIVDVTRRNQCQACRFSKCLQVKMNRDAM

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Nuclear receptor subfamily 2 group E member 1 Orphan receptor that binds DNA as a monomer to hormone response elements (HRE) containing an extended core motif half-site sequence 5'-AAGGTCA-3' in which the 5' flanking nucleotides participate in determining receptor specificity. May be required to pattern anterior brain differentiation (By similarity). Involved in the regulation of retinal development.confidentQ91379
Nuclear receptor subfamily 2 group E member 1 Orphan receptor that binds DNA as a monomer to hormone response elements (HRE) containing an extended core motif half-site sequence 5'-AAGGTCA-3' in which the 5' flanking nucleotides participate in determining receptor specificity (By similarity). Regulates cell cycle progression in neural stem cells of rhe developing brain. Involved in the regulation of retinal development and essential for vision. During retinogenesis, regulates PTEN-Cyclin D expression via binding to the promoter region of PTEN and suppressing its activity. May be involved in retinoic acid receptor (RAR) regulation in retinal cells.confidentQ64104
Nuclear hormone receptor family member nhr-67 Orphan nuclear receptor.confidentQ9XVV3

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0048384 [BP]retinoic acid receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0031641 [BP]regulation of myelinationprobableGO:0051239, GO:0044057, GO:0031644, GO:0032844, GO:0008150, GO:0050793, GO:2000021, GO:2000026, GO:0051960, GO:0023051, GO:0065007, GO:0051969, GO:0010646, GO:0050789, GO:0050794
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0007596 [BP]blood coagulationprobableGO:0032501, GO:0007599, GO:0044707, GO:0050878, GO:0050896, GO:0009611, GO:0042060, GO:0006950, GO:0050817, GO:0008150, GO:0065007, GO:0065008, GO:0044699
GO:0033159 [BP]negative regulation of protein import into nucleus, translocationprobableGO:0033157, GO:0070201, GO:0032879, GO:0060341, GO:0051051, GO:1900180, GO:0051049, GO:0032386, GO:0032387, GO:0090317, GO:0033158, GO:0050794, GO:0008150, GO:0065007, GO:0046822, GO:0048519, GO:0042306, GO:0051223, GO:0051224, GO:0050789, GO:0032880
GO:0044323 [MF]retinoic acid-responsive element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0035270 [BP]endocrine system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0001754 [BP]eye photoreceptor cell differentiationprobableGO:0044707, GO:0030154, GO:0009653, GO:0007275, GO:0044699, GO:0048869, GO:0008150, GO:0048513, GO:0032502, GO:0009887, GO:0032501, GO:0030182, GO:0048592, GO:0009987, GO:0044767, GO:0044763, GO:0048731, GO:0022008, GO:0048699, GO:0007399, GO:0007423, GO:0048856, GO:0046530, GO:0001654
GO:0048568 [BP]embryonic organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0006591 [BP]ornithine metabolic processprobableGO:0044238, GO:0044710, GO:0009987, GO:1901564, GO:0006082, GO:0044237, GO:0006520, GO:0019752, GO:0071704, GO:0006807, GO:0008150, GO:0044281, GO:0008152, GO:0043436, GO:1901605
GO:0016605 [CC]PML bodyprobableGO:0044446, GO:0016604, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0005575, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422
GO:0005652 [CC]nuclear laminaprobableGO:0034399, GO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0007623 [BP]circadian rhythmprobableGO:0048511, GO:0008150
GO:0097305 [BP]response to alcoholprobableGO:1901700, GO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0001972 [MF]retinoic acid bindingprobableGO:0043168, GO:0031406, GO:0019840, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293, GO:0005501
GO:0031490 [MF]chromatin DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:0003682, GO:1901363
GO:0048610 [BP]cellular process involved in reproductionprobableGO:0009987, GO:0008150, GO:0000003
GO:0009416 [BP]response to light stimulusprobableGO:0009314, GO:0050896, GO:0008150, GO:0009628
GO:0071222 [BP]cellular response to lipopolysaccharideprobableGO:0070887, GO:0032496, GO:0044699, GO:0051716, GO:0033993, GO:0009617, GO:0071310, GO:0071219, GO:0071216, GO:0009987, GO:0071396, GO:0008150, GO:0042221, GO:0051707, GO:0010033, GO:0051704, GO:1901700, GO:1901701, GO:0009607, GO:0050896, GO:0002237, GO:0044763
GO:0014070 [BP]response to organic cyclic compoundprobableGO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0048386 [BP]positive regulation of retinoic acid receptor signaling pathwayprobableGO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0048385, GO:0050789, GO:0048522
GO:0005504 [MF]fatty acid bindingprobableGO:0043168, GO:0031406, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0008285 [BP]negative regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0008283 [BP]cell proliferationprobableGO:0008150, GO:0044699
GO:2000189 [BP]positive regulation of cholesterol homeostasisprobableGO:0032846, GO:2000188, GO:0032844, GO:0065007, GO:0048518, GO:0008150, GO:0050789
GO:0007409 [BP]axonogenesisprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0044763, GO:0048731, GO:0022008, GO:0032990, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0048812, GO:0008150
GO:0019048 [BP]virus-host interactionprobableGO:0044419, GO:0044703, GO:0000003, GO:0009987, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0016032, GO:0044403, GO:0051701, GO:0051704
GO:0043068 [BP]positive regulation of programmed cell deathprobableGO:0050794, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0050789, GO:0048522
GO:0019216 [BP]regulation of lipid metabolic processprobableGO:0008150, GO:0065007, GO:0080090, GO:0019222, GO:0050789
GO:0034440 [BP]lipid oxidationprobableGO:0044238, GO:0044710, GO:0006629, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0044255, GO:0030258, GO:0055114
GO:0007619 [BP]courtship behaviorprobableGO:0044703, GO:0000003, GO:0007618, GO:0019098, GO:0007617, GO:0050896, GO:0007610, GO:0022414, GO:0008150, GO:0051705, GO:0051704
GO:0007164 [BP]establishment of tissue polarityprobableGO:0032502, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0021872 [BP]forebrain generation of neuronsprobableGO:0032502, GO:0032501, GO:0048699, GO:0030154, GO:0007420, GO:0007399, GO:0044707, GO:0048869, GO:0009987, GO:0048856, GO:0044763, GO:0044767, GO:0048513, GO:0030900, GO:0008150, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0007417
GO:0031344 [BP]regulation of cell projection organizationprobableGO:0008150, GO:0050794, GO:0065007, GO:0050789, GO:0051128
GO:0010259 [BP]multicellular organismal agingprobableGO:0032502, GO:0032501, GO:0007568, GO:0044707, GO:0044767, GO:0008150, GO:0007275, GO:0044699
GO:0046966 [MF]thyroid hormone receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0000790 [CC]nuclear chromatinprobableGO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0031668 [BP]cellular response to extracellular stimulusprobableGO:0009991, GO:0071496, GO:0009605, GO:0050896, GO:0009987, GO:0051716, GO:0008150, GO:0044763, GO:0007154, GO:0044699
GO:0016290 [MF]palmitoyl-CoA hydrolase activityprobableGO:0016787, GO:0016289, GO:0016790, GO:0016788, GO:0003824, GO:0003674, GO:0047617
GO:0060395 [BP]SMAD protein signal transductionprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0003690 [MF]double-stranded DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0001764 [BP]neuron migrationprobableGO:0040011, GO:0032502, GO:0048699, GO:0048856, GO:0044707, GO:0007399, GO:0048870, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0006928, GO:0008150, GO:0051674, GO:0044763, GO:0007275, GO:0048731, GO:0022008, GO:0016477, GO:0051179, GO:0044699
GO:0006367 [BP]transcription initiation from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0006352, GO:0019438
GO:0020037 [MF]heme bindingprobableGO:0005488, GO:0097159, GO:0003674, GO:1901363, GO:0046906
GO:0055088 [BP]lipid homeostasisprobableGO:0042592, GO:0008150, GO:0065008, GO:0065007, GO:0048878
GO:0007548 [BP]sex differentiationprobableGO:0032502, GO:0003006, GO:0008150, GO:0000003, GO:0022414
GO:0017085 [BP]response to insecticideprobableGO:0008150, GO:0042221, GO:0050896, GO:0009636
GO:0006637 [BP]acyl-CoA metabolic processprobableGO:0035383, GO:0051186, GO:0006732, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0006793
GO:0019899 [MF]enzyme bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0042974 [MF]retinoic acid receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0021954 [BP]central nervous system neuron developmentprobableGO:0048666, GO:0032502, GO:0048699, GO:0048856, GO:0030182, GO:0007399, GO:0008150, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0048468, GO:0044767, GO:0009987, GO:0044763, GO:0044699, GO:0048731, GO:0022008, GO:0007275, GO:0021953, GO:0007417
GO:0048608 [BP]reproductive structure developmentprobableGO:0032502, GO:0032501, GO:0000003, GO:0044707, GO:0022414, GO:0061458, GO:0048856, GO:0003006, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0071542 [BP]dopaminergic neuron differentiationprobableGO:0032502, GO:0048699, GO:0009987, GO:0030182, GO:0007399, GO:0044707, GO:0048869, GO:0030154, GO:0008150, GO:0032501, GO:0044763, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0048856
GO:0014706 [BP]striated muscle tissue developmentprobableGO:0032502, GO:0048856, GO:0008150, GO:0009888, GO:0060537
GO:0045216 [BP]cell-cell junction organizationprobableGO:0034330, GO:0009987, GO:0016043, GO:0044763, GO:0044699, GO:0008150, GO:0071840
GO:0042981 [BP]regulation of apoptotic processprobableGO:0050794, GO:0043067, GO:0008150, GO:0065007, GO:0010941, GO:0050789
GO:0045930 [BP]negative regulation of mitotic cell cycleprobableGO:0007346, GO:0045786, GO:0051726, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0003705 [MF]RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0003714 [MF]transcription corepressor activityprobableGO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0008502 [MF]melatonin receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871
GO:0032332 [BP]positive regulation of chondrocyte differentiationprobableGO:0051094, GO:0050793, GO:0050794, GO:0045597, GO:0032330, GO:0045595, GO:0061035, GO:2000026, GO:0008150, GO:0051239, GO:0048518, GO:0065007, GO:0050789, GO:0048522
GO:0007600 [BP]sensory perceptionprobableGO:0032501, GO:0044707, GO:0050877, GO:0008150, GO:0044699, GO:0003008
GO:0030424 [CC]axonprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0043433 [BP]negative regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0044092, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0065009, GO:0051252, GO:0010468
GO:0010243 [BP]response to organic nitrogenprobableGO:0009719, GO:0050896, GO:1901698, GO:0008150, GO:0042221, GO:0010033
GO:0001077 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcriptionprobableGO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0033554 [BP]cellular response to stressprobableGO:0051716, GO:0050896, GO:0009987, GO:0006950, GO:0044763, GO:0008150, GO:0044699
GO:0060560 [BP]developmental growth involved in morphogenesisprobableGO:0032502, GO:0040007, GO:0048589, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0030375 [MF]thyroid hormone receptor coactivator activityprobableGO:0030545, GO:0030546, GO:0003713, GO:0003712, GO:0030374, GO:0003674, GO:0000989, GO:0000988, GO:0010861
GO:0048732 [BP]gland developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:1901615 [BP]organic hydroxy compound metabolic processprobableGO:0071704, GO:0008150, GO:0008152
GO:0008232 [CC]activator ecdysone receptor complexprobableGO:0031974, GO:0043229, GO:0008230, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0043235, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0005667, GO:0044424, GO:0044422
GO:0001701 [BP]in utero embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0042809 [MF]vitamin D receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0032870 [BP]cellular response to hormone stimulusprobableGO:0071495, GO:0009719, GO:0051716, GO:0009725, GO:0050896, GO:0009987, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0021549 [BP]cerebellum developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0022037, GO:0044767, GO:0048513, GO:0008150, GO:0030902, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0042053 [BP]regulation of dopamine metabolic processprobableGO:0080090, GO:0019222, GO:0042069, GO:0031323, GO:0050794, GO:0033238, GO:0065007, GO:0051171, GO:0008150, GO:0050789
GO:0009791 [BP]post-embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0008150, GO:0007275, GO:0044699
GO:0022603 [BP]regulation of anatomical structure morphogenesisprobableGO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0033057 [BP]multicellular organismal reproductive behaviorprobableGO:0032501, GO:0048609, GO:0032504, GO:0019098, GO:0050896, GO:0044706, GO:0007610, GO:0022414, GO:0008150, GO:0000003, GO:0051704
GO:0000977 [MF]RNA polymerase II regulatory region sequence-specific DNA bindingprobableGO:0043565, GO:0044212, GO:0001067, GO:0003677, GO:0001012, GO:0000976, GO:0005488, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363
GO:0072539 [BP]T-helper 17 cell differentiationprobableGO:0044707, GO:0072538, GO:0046632, GO:0046631, GO:0045321, GO:0032501, GO:0007275, GO:0044699, GO:0042093, GO:0002286, GO:0002287, GO:0002285, GO:0048869, GO:0002263, GO:0002366, GO:0048534, GO:0043367, GO:0032502, GO:0030154, GO:0030217, GO:0009987, GO:0048731, GO:0044767, GO:0001775, GO:0046649, GO:0008150, GO:0042110, GO:0006955, GO:0002521, GO:0002520, GO:0048513, GO:0002293, GO:0002292, GO:0002294, GO:0002460, GO:0050896, GO:0048856, GO:0044763, GO:0002376, GO:0002250, GO:0030098, GO:0002252, GO:0030097, GO:0035710
GO:0004886 [MF]9-cis retinoic acid receptor activityprobableGO:0003708, GO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0004887 [MF]thyroid hormone receptor activityprobableGO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0023019 [BP]signal transduction involved in regulation of gene expressionprobableGO:0044700, GO:0051716, GO:0019222, GO:0008150, GO:0060255, GO:0050896, GO:0009987, GO:0050794, GO:0050789, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0010468, GO:0044699
GO:0001078 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcriptionprobableGO:0001227, GO:0003700, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0007517 [BP]muscle organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0061061, GO:0048731, GO:0007275, GO:0044699
GO:0010035 [BP]response to inorganic substanceprobableGO:0042221, GO:0050896, GO:0008150
GO:0070644 [MF]vitamin D response element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0040034 [BP]regulation of development, heterochronicprobableGO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0045995 [BP]regulation of embryonic developmentprobableGO:0050793, GO:0008150, GO:0065007, GO:0051239, GO:2000026, GO:0050789
GO:0044708 [BP]single-organism behaviorprobableGO:0050896, GO:0008150, GO:0007610
GO:0010871 [BP]negative regulation of receptor biosynthetic processprobableGO:0010605, GO:0019222, GO:0009890, GO:0060255, GO:0009889, GO:0031324, GO:0031323, GO:0050794, GO:0010869, GO:0050789, GO:0010556, GO:0065007, GO:0008150, GO:0048519, GO:0009892, GO:0010558, GO:0048523
GO:0042524 [BP]negative regulation of tyrosine phosphorylation of Stat5 proteinprobableGO:0010563, GO:0019220, GO:0080090, GO:0019222, GO:0048585, GO:0031324, GO:0048583, GO:0023057, GO:0010648, GO:0023051, GO:0009892, GO:0010646, GO:0010627, GO:0050789, GO:0051248, GO:0010605, GO:0009968, GO:0009966, GO:0045936, GO:0051246, GO:0042532, GO:0065007, GO:0031399, GO:0048519, GO:0010741, GO:0042325, GO:0046426, GO:0046425, GO:0060255, GO:0031323, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042509, GO:0042522, GO:0032269, GO:0042326, GO:0050730, GO:0031400, GO:0050732, GO:0001933, GO:0001932, GO:0048523
GO:0060173 [BP]limb developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0008150, GO:0044699, GO:0007275, GO:0048736
GO:0016042 [BP]lipid catabolic processprobableGO:0044238, GO:1901575, GO:0006629, GO:0044710, GO:0071704, GO:0008150, GO:0008152, GO:0009056
GO:0048471 [CC]perinuclear region of cytoplasmprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0060838 [BP]lymphatic endothelial cell fate commitmentprobableGO:0030154, GO:0072359, GO:0072358, GO:0045446, GO:0007275, GO:0044699, GO:0003158, GO:0001944, GO:0001945, GO:0008150, GO:0060836, GO:0030855, GO:0060839, GO:0032502, GO:0009987, GO:0032501, GO:0060429, GO:0009888, GO:0044767, GO:0044763, GO:0072148, GO:0045165, GO:0044707, GO:0048856, GO:0048869, GO:0048731
GO:0045177 [CC]apical part of cellprobableGO:0005575, GO:0044464, GO:0005623
GO:0034144 [BP]negative regulation of toll-like receptor 4 signaling pathwayprobableGO:0009968, GO:0050794, GO:0009966, GO:0048583, GO:0048585, GO:0023051, GO:0034122, GO:0034121, GO:0008150, GO:0023057, GO:0065007, GO:0002682, GO:0002683, GO:0034143, GO:0048519, GO:0010646, GO:0050789, GO:0048523, GO:0010648
GO:0007507 [BP]heart developmentprobableGO:0032502, GO:0048513, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045736 [BP]negative regulation of cyclin-dependent protein serine/threonine kinase activityprobableGO:0033673, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0031324, GO:0031323, GO:0009892, GO:0071901, GO:0071900, GO:0043086, GO:0051248, GO:0045786, GO:0051348, GO:0051246, GO:0050789, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0006469, GO:0045936, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0010605, GO:0042325, GO:0032269, GO:0042326, GO:0050790, GO:0051726, GO:0010563, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0000079, GO:0048523
GO:0045596 [BP]negative regulation of cell differentiationprobableGO:0051093, GO:0050793, GO:0050794, GO:0008150, GO:0045595, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0001893 [BP]maternal placenta developmentprobableGO:0060135, GO:0007275, GO:0044699, GO:0000003, GO:0048513, GO:0044706, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0044767, GO:0022414, GO:0008150, GO:0001890, GO:0051704, GO:0044703, GO:0044702, GO:0044707, GO:0003006, GO:0007565, GO:0048856, GO:0048731
GO:0006805 [BP]xenobiotic metabolic processprobableGO:0051716, GO:0008152, GO:0050896, GO:0009987, GO:0044763, GO:0009410, GO:0044237, GO:0071466, GO:0008150, GO:0070887, GO:0042221, GO:0044699
GO:0045778 [BP]positive regulation of ossificationprobableGO:0051240, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0030278, GO:0050789
GO:0035357 [BP]peroxisome proliferator activated receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0002009 [BP]morphogenesis of an epitheliumprobableGO:0032502, GO:0048856, GO:0060429, GO:0009888, GO:0044767, GO:0008150, GO:0048729, GO:0009653, GO:0044699
GO:0071300 [BP]cellular response to retinoic acidprobableGO:1901700, GO:1901701, GO:0032526, GO:0033993, GO:0050896, GO:0009987, GO:0071396, GO:0051716, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0030308 [BP]negative regulation of cell growthprobableGO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0010594 [BP]regulation of endothelial cell migrationprobableGO:0051270, GO:0010632, GO:0040012, GO:0008150, GO:0030334, GO:2000145, GO:0051239, GO:0065007, GO:0032879, GO:0050794, GO:0050789

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 2HAN, chain A
Confidence level:very confident
Coverage over the Query: 61-134
View the alignment between query and template
View the model in PyMOL